Scholars Central

Research articlePublished 17 Aug 2021

Evaluating the Immunity to Tetanus in Adults with the Enzyme-Linked Immunosorbent Assay

Authors: Banu Karaca, Nur Yapar, Ayse Yuce

1Department of Infectious Diseases, Katip Celebi University, Izmir, Turkey; 2Department of Infectious Diseases, Dokuz Eylul University, Izmir, Turkey

Journal of Infectious Diseases & Therapy

Volume 9 · Issue 5 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Tetanus is a worldwide preventable disease with vaccination having an incidence of approximately one million, which causes mortality especially in neonates in developing countries and in individuals over 60 years old in developed countries. The disease particularly affects unvaccinated people or those with an incomplete vaccination schedule. It has been reported in literature that immunity to tetanus diminishes with increased age. The aim of this study was to determine the immunity to tetanus and the need for booster immunization in the adult population in Turkey. Methods and findings: A total of 339 blood samples were collected from patients aged between 20-81 years. Tetanus antitoxin levels were studied with the Enzyme Linked Imumunosorbent Assay (ELISA) method (Genzyme Virotech Germany). Titers <0.1 IU/ml were considered to show insufficient immunity to tetanus. Of the studied population, 39.5% had insufficient immunity against tetanus. With increasing age, tetanus immunity was seen to decrease. The immunity to tetanus was seen to be higher in patients who had received a booster immunization in the past 5 years compared with the groups with a last booster immunization 5-10 years previously or more than 10 years ago. A higher rate was also determined in the female population with a pregnancy history in the last 5 years compared with the groups with pregnancy 5-10 years previously or more than 10 years ago. Conclusion: Booster doses for adults are needed. The present vaccination schedule must include boosters every 10 years in order to provide immunity against tetanus for all the population.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Banu Karaca”
  • BylineArticles whose byline prints “Nur Yapar”
  • BylineArticles whose byline prints “Ayse Yuce”